1 Min Read
Nov 2 (Reuters) - Aratana Therapeutics Inc
* Aratana Therapeutics reports third quarter 2017 financial results
* Q3 loss per share $0.21
* Q3 revenue $6.2 million Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.